HEADER TRANSFERASE 30-APR-14 4D0W TITLE PYRROLE-3-CARBOXAMIDES AS POTENT AND SELECTIVE JAK2 INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 835-1132; COMPND 5 SYNONYM: JANUS KINASE 2, JAK-2; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE, DRUG DISCOVERY, PROTEIN KINASE INHIBITORS, STRUCTURE- KEYWDS 2 ACTIVITY RELATIONSHIP, POLYCYTHEMIA VERA, TUMOUR CELL PROLIFERATION KEYWDS 3 INHIBITION, ANTI-CANCER AGENTS EXPDTA X-RAY DIFFRACTION AUTHOR J.BERTRAND,G.CANEVARI,M.FASOLINI,M.G.BRASCA,M.NESI,N.AVANZI, AUTHOR 2 D.BALLINARI,T.BANDIERA,S.BINDI,D.CARENZI,D.CASERO,L.CERIANI, AUTHOR 3 M.CIOMEI,A.CIRLA,M.COLOMBO,S.CRIBIOLI,C.CRISTIANI,F.DELLA VEDOVA, AUTHOR 4 G.FACHIN,E.R.FELDER,A.GALVANI,A.ISACCHI,D.MIRIZZI,I.MOTTO,A.PANZERI, AUTHOR 5 E.PESENTI,P.VIANELLO,P.GNOCCHI,D.DONATI REVDAT 5 20-DEC-23 4D0W 1 REMARK REVDAT 4 24-APR-19 4D0W 1 SOURCE REVDAT 3 06-MAR-19 4D0W 1 REMARK LINK REVDAT 2 10-SEP-14 4D0W 1 JRNL REVDAT 1 23-JUL-14 4D0W 0 JRNL AUTH M.G.BRASCA,M.NESI,N.AVANZI,D.BALLINARI,T.BANDIERA, JRNL AUTH 2 J.BERTRAND,S.BINDI,G.CANEVARI,D.CARENZI,D.CASERO,L.CERIANI, JRNL AUTH 3 M.CIOMEI,A.CIRLA,M.COLOMBO,S.CRIBIOLI,C.CRISTIANI, JRNL AUTH 4 F.DELLA VEDOVA,G.FACHIN,M.FASOLINI,E.R.FELDER,A.GALVANI, JRNL AUTH 5 A.ISACCHI,D.MIRIZZI,I.MOTTO,A.PANZERI,E.PESENTI,P.VIANELLO, JRNL AUTH 6 P.GNOCCHI,D.DONATI JRNL TITL PYRROLE-3-CARBOXAMIDES AS POTENT AND SELECTIVE JAK2 JRNL TITL 2 INHIBITORS. JRNL REF BIOORG.MED.CHEM. V. 22 4998 2014 JRNL REFN ISSN 0968-0896 JRNL PMID 25009002 JRNL DOI 10.1016/J.BMC.2014.06.025 REMARK 2 REMARK 2 RESOLUTION. 1.77 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.77 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 95.3 REMARK 3 NUMBER OF REFLECTIONS : 29071 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.175 REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1532 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.77 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.82 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1499 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 69.01 REMARK 3 BIN R VALUE (WORKING SET) : 0.2850 REMARK 3 BIN FREE R VALUE SET COUNT : 73 REMARK 3 BIN FREE R VALUE : 0.3860 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2419 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 29 REMARK 3 SOLVENT ATOMS : 156 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.06 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.01000 REMARK 3 B22 (A**2) : 0.95000 REMARK 3 B33 (A**2) : 0.06000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.119 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.118 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.077 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.465 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.965 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.948 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2530 ; 0.022 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3415 ; 2.163 ; 1.993 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 299 ; 6.141 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 128 ;38.599 ;23.906 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 474 ;17.003 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;23.859 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 354 ; 0.190 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1928 ; 0.012 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4D0W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-APR-14. REMARK 100 THE DEPOSITION ID IS D_1290060481. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-MAR-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0090 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29746 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.770 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.6 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.77 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.83 REMARK 200 COMPLETENESS FOR SHELL (%) : 70.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.44000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.860 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 2B7A REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.5-2.2 M SODIUM MALONATE PH 7 VAPOUR REMARK 280 DIFFUSION TECHNIQUE 293 K, VAPOR DIFFUSION REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 34.11600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 34.11600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 46.62300 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 51.04850 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 46.62300 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 51.04850 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 34.11600 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 46.62300 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 51.04850 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 34.11600 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 46.62300 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 51.04850 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 835 REMARK 465 PHE A 836 REMARK 465 GLU A 837 REMARK 465 ASP A 838 REMARK 465 ASN A 859 REMARK 465 ALA A 1131 REMARK 465 GLY A 1132 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 HIS A1077 CG HIS A1077 CD2 0.056 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 840 CB - CG - OD1 ANGL. DEV. = 7.5 DEGREES REMARK 500 LEU A 967 CA - CB - CG ANGL. DEV. = 15.0 DEGREES REMARK 500 ASP A 976 CB - CG - OD1 ANGL. DEV. = 6.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 873 19.36 -146.19 REMARK 500 LYS A 945 -133.64 51.90 REMARK 500 ARG A 975 -8.84 72.13 REMARK 500 ASP A 976 41.63 -142.17 REMARK 500 TRP A1106 47.14 -95.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 2131 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VVQ A 2132 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4D0X RELATED DB: PDB REMARK 900 PYRROLE-3-CARBOXAMIDES AS POTENT AND SELECTIVE JAK2 INHIBITORS REMARK 900 RELATED ID: 4D1S RELATED DB: PDB REMARK 900 PYRROLE-3-CARBOXAMIDES AS POTENT AND SELECTIVE JAK2 INHIBITORS DBREF 4D0W A 835 1132 UNP O60674 JAK2_HUMAN 835 1132 SEQRES 1 A 298 ALA PHE GLU ASP ARG ASP PRO THR GLN PHE GLU GLU ARG SEQRES 2 A 298 HIS LEU LYS PHE LEU GLN GLN LEU GLY LYS GLY ASN PHE SEQRES 3 A 298 GLY SER VAL GLU MET CYS ARG TYR ASP PRO LEU GLN ASP SEQRES 4 A 298 ASN THR GLY GLU VAL VAL ALA VAL LYS LYS LEU GLN HIS SEQRES 5 A 298 SER THR GLU GLU HIS LEU ARG ASP PHE GLU ARG GLU ILE SEQRES 6 A 298 GLU ILE LEU LYS SER LEU GLN HIS ASP ASN ILE VAL LYS SEQRES 7 A 298 TYR LYS GLY VAL CYS TYR SER ALA GLY ARG ARG ASN LEU SEQRES 8 A 298 LYS LEU ILE MET GLU TYR LEU PRO TYR GLY SER LEU ARG SEQRES 9 A 298 ASP TYR LEU GLN LYS HIS LYS GLU ARG ILE ASP HIS ILE SEQRES 10 A 298 LYS LEU LEU GLN TYR THR SER GLN ILE CYS LYS GLY MET SEQRES 11 A 298 GLU TYR LEU GLY THR LYS ARG TYR ILE HIS ARG ASP LEU SEQRES 12 A 298 ALA THR ARG ASN ILE LEU VAL GLU ASN GLU ASN ARG VAL SEQRES 13 A 298 LYS ILE GLY ASP PHE GLY LEU THR LYS VAL LEU PRO GLN SEQRES 14 A 298 ASP LYS GLU PTR PTR LYS VAL LYS GLU PRO GLY GLU SER SEQRES 15 A 298 PRO ILE PHE TRP TYR ALA PRO GLU SER LEU THR GLU SER SEQRES 16 A 298 LYS PHE SER VAL ALA SER ASP VAL TRP SER PHE GLY VAL SEQRES 17 A 298 VAL LEU TYR GLU LEU PHE THR TYR ILE GLU LYS SER LYS SEQRES 18 A 298 SER PRO PRO ALA GLU PHE MET ARG MET ILE GLY ASN ASP SEQRES 19 A 298 LYS GLN GLY GLN MET ILE VAL PHE HIS LEU ILE GLU LEU SEQRES 20 A 298 LEU LYS ASN ASN GLY ARG LEU PRO ARG PRO ASP GLY CYS SEQRES 21 A 298 PRO ASP GLU ILE TYR MET ILE MET THR GLU CYS TRP ASN SEQRES 22 A 298 ASN ASN VAL ASN GLN ARG PRO SER PHE ARG ASP LEU ALA SEQRES 23 A 298 LEU ARG VAL ASP GLN ILE ARG ASP ASN MET ALA GLY MODRES 4D0W PTR A 1007 TYR O-PHOSPHOTYROSINE MODRES 4D0W PTR A 1008 TYR O-PHOSPHOTYROSINE HET PTR A1007 16 HET PTR A1008 16 HET GOL A2131 6 HET VVQ A2132 23 HETNAM PTR O-PHOSPHOTYROSINE HETNAM GOL GLYCEROL HETNAM VVQ 5-(2-AMINOPYRIMIDIN-4-YL)-2-(5-CHLORO-2-METHYLPHENYL)- HETNAM 2 VVQ 1H-PYRROLE-3-CARBOXAMIDE HETSYN PTR PHOSPHONOTYROSINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 2 GOL C3 H8 O3 FORMUL 3 VVQ C16 H14 CL N5 O FORMUL 4 HOH *156(H2 O) HELIX 1 1 GLU A 845 ARG A 847 5 3 HELIX 2 2 THR A 888 SER A 904 1 17 HELIX 3 3 SER A 936 LYS A 945 1 10 HELIX 4 4 GLU A 946 ILE A 948 5 3 HELIX 5 5 ASP A 949 LYS A 970 1 22 HELIX 6 6 ALA A 978 ARG A 980 5 3 HELIX 7 7 PRO A 1017 TYR A 1021 5 5 HELIX 8 8 ALA A 1022 SER A 1029 1 8 HELIX 9 9 VAL A 1033 THR A 1049 1 17 HELIX 10 10 GLU A 1052 LYS A 1055 5 4 HELIX 11 11 SER A 1056 GLY A 1066 1 11 HELIX 12 12 GLY A 1071 ASN A 1084 1 14 HELIX 13 13 PRO A 1095 TRP A 1106 1 12 HELIX 14 14 ASN A 1109 ARG A 1113 5 5 HELIX 15 15 SER A 1115 MET A 1130 1 16 SHEET 1 AA 5 LEU A 849 LYS A 857 0 SHEET 2 AA 5 GLY A 861 TYR A 868 -1 O VAL A 863 N LEU A 855 SHEET 3 AA 5 GLU A 877 LEU A 884 -1 O GLU A 877 N TYR A 868 SHEET 4 AA 5 LEU A 925 GLU A 930 -1 O LEU A 927 N LYS A 882 SHEET 5 AA 5 TYR A 913 TYR A 918 -1 N LYS A 914 O ILE A 928 SHEET 1 AB 2 TYR A 972 ILE A 973 0 SHEET 2 AB 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973 SHEET 1 AC 2 ILE A 982 ASN A 986 0 SHEET 2 AC 2 ARG A 989 ILE A 992 -1 O ARG A 989 N GLU A 985 SHEET 1 AD 2 PTR A1007 LYS A1009 0 SHEET 2 AD 2 LYS A1030 SER A1032 -1 O PHE A1031 N PTR A1008 LINK C GLU A1006 N PTR A1007 1555 1555 1.34 LINK C PTR A1007 N PTR A1008 1555 1555 1.33 LINK C PTR A1008 N LYS A1009 1555 1555 1.33 SITE 1 AC1 4 TYR A 934 TYR A 940 LYS A 943 HIS A 944 SITE 1 AC2 18 LEU A 855 GLY A 856 GLY A 858 GLY A 861 SITE 2 AC2 18 VAL A 863 ALA A 880 GLU A 930 TYR A 931 SITE 3 AC2 18 LEU A 932 ARG A 980 ASN A 981 LEU A 983 SITE 4 AC2 18 ASP A 994 HOH A3019 HOH A3058 HOH A3061 SITE 5 AC2 18 HOH A3083 HOH A3090 CRYST1 93.246 102.097 68.232 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010724 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009795 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014656 0.00000